ArticleJournal of endocrinology and diabetes
Telemedicine and Diabetic Retinopathy: Review of Published Screening Programs.
Article in Journal of endocrinology and diabetes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed.
- Effectiveness of Teleretinal Imaging-Based Hospital Referral Compared With Universal Referral in Identifying Diabetic Retinopathy: A Cluster Randomized Clinical Trial.JAMA ophthalmology · 2019Trial
- The Underutilized Ocular Fundus in Emergency Departments: Current Progress and Future Prospect of Imaging and Artificial Intelligence for Patient Care.Ophthalmology science · 2026Review
- Clinical, Socioeconomic, and Demographic Factors Associated with Diabetic Retinopathy in a Hospital-Based Screening Program: A Cross-Sectional Study in Oslo, Norway.Healthcare (Basel, Switzerland) · 2026Article
- Integrating Ophthalmology, Endocrinology, and Digital Health: A Bibliometric Analysis of Telemedicine for Diabetic Retinopathy.Healthcare (Basel, Switzerland) · 2026Review
- Digital eyes on diabetes: a systematic review of attitudes toward telemedicine-based retinopathy screening.Oxford open digital health · 2026Article
- Enhanced performance in automated diabetic retinopathy diagnosis achieved through Voronoi diagrams and artificial intelligence.Scientific reports · 2025Article
- A deep learning-based ADRPPA algorithm for the prediction of diabetic retinopathy progression.Scientific reports · 2024Article
- Article
- Evaluation of Sensitivity and Specificity of Acuity 360 Telemedicine Vision Screening System.Clinical ophthalmology (Auckland, N.Z.) · 2024Article
- Protocol for a systematic review and meta-analysis of the diagnostic accuracy of artificial intelligence for grading of ophthalmology imaging modalities.Diagnostic and prognostic research · 2022Article
- Eye Care During the COVID-19 Pandemic: A Report on Patients' Perceptions and Experiences, an Asian Perspective.Ophthalmology and therapy · 2022Article
- Urgent Virtual Eye Assessments During the COVID-19 Pandemic.Clinical ophthalmology (Auckland, N.Z.) · 2022Article
- Validation of an Automated Screening System for Diabetic Retinopathy Operating under Real Clinical Conditions.Journal of clinical medicine · 2021Article
- Telemedicine in diabetic retinopathy screening in India.Indian journal of ophthalmology · 2021Review
- Teleophthalmology and Artificial Intelligence As Game Changers in Ophthalmic Care After the COVID-19 Pandemic.Cureus · 2021Review
- Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective.Progress in retinal and eye research · 2021Review
- Tele-health in pediatric ophthalmology: Promises and pitfalls.Indian journal of ophthalmology · 2021Article
- The Indian Health Service Primary Care-Based Teleophthalmology Program for Diabetic Eye Disease Surveillance and Management.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2020Article
- What COVID-19 has taught us: lessons from around the globe.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2020Article
- Diving Deep into Deep Learning: An Update on Artificial Intelligence in Retina.Current ophthalmology reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundDiabetic Retinopathy (DR) is a leading cause of blindness worldwide even though successful treatments exist. Improving screening and treatment could avoid many cases of vision loss. However, due to an increasing prevalence of diabetes, traditional in-person screening for DR for every diabetic patient is not feasible. Telemedicine is one viable solution to provide high-quality and efficient screening to large number of diabetic patients. PURPOSE: To provide a narrative review of large DR telemedicine screening programs.
methodsArticles were identified through a comprehensive search of the English-language literature published between 2000 and 2014. Telemedicine screening programs were included for review if they had published data on at least 150 patients and had available validation studies supporting their model. Screening programs were then categorized according to their American Telemedicine Association Validation Level.
resultsSeven programs from the US and abroad were identified and included in the review. Three programs were Category 1 programs (Ophdiat, EyePacs, and Digiscope), two were Category 2 programs (Eye Check, NHS Diabetic Eye Screening Program), and two were Category 3 programs (Joslin Vision Network, Alberta Screening Program). No program was identified that claimed category 4 status. Programs ranged from community or city level programs to large nationwide programs including millions of individuals. The programs demonstrated a high level of clinical accuracy in screening for DR. There was no consensus amongst the programs regarding the need for dilation, need for stereoscopic images, or the level of training for approved image graders.
conclusionTelemedicine programs have been clinically validated and successfully implemented across the globe. They can provide a high-level of clinical accuracy for screening for DR while improving patient access in a cost-effective and scalable manner.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.